tiprankstipranks
Trending News
More News >
IntelliPharmaCeutics International (IPCIQ)
OTHER OTC:IPCIQ
US Market

IntelliPharmaCeutics International (IPCIQ) Income Statement

Compare
145 Followers

IntelliPharmaCeutics International Income Statement

Last quarter (Q3 2023), IntelliPharmaCeutics International's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, IntelliPharmaCeutics International's net income was $-1.89M. See IntelliPharmaCeutics International’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Nov 22Nov 21Nov 20Nov 19Nov 18
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 65.73K$ ―$ 1.40M$ 3.45M$ 1.59M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 206.06K$ 261.52K$ 415.38K$ 505.80K$ 610.38K
EBITDA
$ -2.39M$ -4.45M$ -1.97M$ -7.34M$ -12.88M
Operating Income
$ -2.85M$ -4.17M$ -4.68M$ -7.83M$ -13.33M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -2.89M$ -5.15M$ -3.39M$ -8.08M$ -13.75M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

IntelliPharmaCeutics International Earnings and Revenue History